Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC ...
Ivonescimab shows promising anti-tumor activity and safety in CRC, TNBC, and HNSCC, with encouraging Phase II data supporting its clinical development expansion beyond metastatic NSCLC, as presented at ESMO 2024.
Related Clinical Trials
Reference News
Promising Anti-Tumor Activity and Safety of Ivonescimab in Combination Therapies in CRC ...
Ivonescimab shows promising anti-tumor activity and safety in CRC, TNBC, and HNSCC, with encouraging Phase II data supporting its clinical development expansion beyond metastatic NSCLC, as presented at ESMO 2024.